Harry W. Alcorn Jr., Senior VP, Clinical Operations at DiaMedica Therapeutics Inc. (DMAC), bought 20,721 shares at $3.09 ($64K) on 2021-08-16, disclosed to the SEC on 2021-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.06 | 322 | $985 | 1.5% |
| 2 | $3.07 | 399 | $1K | 1.9% |
| 3 | $3.09 | 20,000 | $62K | 96.5% |
| Total | $3.09 avg | 20,721 | $64K | 100% |
| Filing → |
| DMAC | BUY | 2019-03-29 | $669 | — | Filing → |
| DMAC | BUY | 2018-12-11 | $4K | — | Filing → |